Skip to content

Author

J. Loscalzo

We have 3 of 81 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Deciphering the Mechanisms of Statin–Ezetimibe Drug Combinations Using Boolean Logical Modeling and Transcriptomic Data

Drug Combinations offer increased therapeutic efficacy and reduced toxicity compared with single agents. Understanding a drug combination's mechanisms of action (MoA) can provide important insights into therapeutic efficacy. The MoA of many FDA‐approved drugs, however, often remains unclear. To decipher the underlying...

Rui-Sheng Wang, Matteo Pedrelli, O. Ahmed et al. · 0 citations
Open access Aug 2026

2-Hydroxyglutarate Redirects Fatty Acid Partitioning to Mitigate Lipotoxic Stress and Preserve Metabolic Fuel

The role of 2-hydroxyglutarate in lipid metabolism is currently unknown. Here we show that 2HG redistributes the partitioning of fatty acids into triglyceride storage and away from membrane phospholipid synthesis, mitochondrial oxidation, and lipotoxic intermediates. In primary human cardiac and vascular cells, both en...

N. Vigder, Amit Chandra, Nishith M. Shrimali et al. · 0 citations
Review Open access Sep 2026

Artificial intelligence in clinical trials—state of the evidence, gaps, and next steps

This manuscript defines AI-as-intervention as AI whose output is itself part of the assigned clinical intervention being evaluated for its effect on participant care or outcomes, and AI-for-trial-operations as AI used to support trial design, conduct, or analysis without itself constituting the treatment under study.

A. Armoundas, C. Tarabanis, J. Loscalzo · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.